Gene expression profiling tests to guide adjuvant chemotherapy decisions in lymph node-positive early breast cancer: a systematic review.

Breast Cancer Res Treat · 2025 · PMC11930876 · PMID 39899163

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

borderline significantno p-value reported

Results for 10-year BCSS and OS were similar, with significant or borderline significant effects of chemotherapy in the high-risk group only, and some significant interaction tests (Table 2 ).

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.